Main Article Content
The emergence of severe acute respiratory syndrome coronavirus 2 (SARSCoV2), and the subsequent announcement by the World Health Organization of a global pandemic, has altered health care across the public and private sectors. Clearly, coronavirus disease 2019 (COVID-19) is having a huge impact on general practitioners, emergency physicians, respiratory physicians, in tensivists and related staff and is also impacting the day-to- day delivery of chronic health care, Conditions such as type 1 and type 2 diabetes require regular, usually face-to- face contact with GPs, endocrinologists, diabetes educators, dieticians and podiatrists to optimize glycemic control. However, with recommendations regarding social isolation to minimize spread of COVID-19,1 the delivery of such health care is increasingly being delivered using telehealth. This has been greatly facilitated in the Saudi Arabia, Because of the threat that COVID-19 poses to people with hyperglycemia and diabetes, the need for effective management in the outpatient setting is paramount, and the role of the PCP in limiting the risk of severe COVID-19 disease through effective management of blood glucose is crucial. Uncontrolled diabetes and/or hyperglycemia is associated with severe COVID-19 disease and increased mortality.
Aim of the study: To assessment the importance of diabetes management during the COVID-19 pandemic in Makkah Al-Mukarramah Saudi Arabia.
Method: cross sectional study conducted about importance of diabetes management during the COVID-19 pandemic in Makkah among patients attending primary healthcare centers in Makkah City in 2022. Our total participants were (200)
Results: shows that most of the participants (35.0%) were in the age group 35-45 years. majority of them were male (53.0%). Educational level the majority of participant are high education were(37.0%) also nationality the majority of participant are Saudi were(75.0%). while smoker were(39.0%).
Conclusion: The availability of several COVID-19 vaccines has provided hope that high COVID-19 infection rates will be brought under control in the coming months. However, with concerns over new variants and overwhelmed healthcare systems, it remains vitally important to preserve the health of those who are most at risk of diabetes disease. Further, despite encouraging initial reports of the effectiveness of vaccines in older adults, the effectiveness in those with diabetes who may have compromised immune systems remains to be seen